Cargando…
Characteristics and outcomes of elderly patients with Parkinson's disease hospitalized due to COVID‑19‑associated pneumonia
Patients with Parkinson's disease (PD) and coronavirus disease 2019 (COVID-19)-associated pneumonia present, according to the literature, high mortality rates due to the nature of the disease, advanced age, and underlying diseases. Most available studies, however, refer to the first waves of th...
Autores principales: | Georgakopoulou, Vasiliki Epameinondas, Gkoufa, Aikaterini, Bougea, Anastasia, Basoulis, Dimitrios, Tsakanikas, Aristeidis, Makrodimitri, Sotiria, Karamanakos, Georgios, Spandidos, Demetrios A., Angelopoulou, Efthalia, Sipsas, Nikolaos V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336924/ https://www.ncbi.nlm.nih.gov/pubmed/37448768 http://dx.doi.org/10.3892/mi.2023.94 |
Ejemplares similares
-
Predictors of COVID‑19‑associated mortality among hospitalized elderly patients with dementia
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023) -
Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023) -
Factors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2022) -
Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study
por: Basoulis, Dimitrios, et al.
Publicado: (2023) -
New‑onset non‑motor symptoms in patients with Parkinson's disease and post‑COVID‑19 syndrome: A prospective cross‑sectional study
por: Bougea, Anastasia, et al.
Publicado: (2023)